Journal of Diabetes and Its Complications
Volume 19, Issue 6 , Pages 313-318, November 2005

Presence of the metabolic syndrome distinguishes patients with ketosis-prone diabetes who have a Type 2 diabetic phenotype

  • Max E. Otiniano

      Affiliations

    • Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
  • ,
  • Ashok Balasubramanyam

      Affiliations

    • Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    • Endocrine Service, Ben Taub General Hospital, Houston, TX, USA
  • ,
  • Mario Maldonado

      Affiliations

    • Division of Endocrinology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
    • Endocrine Service, Ben Taub General Hospital, Houston, TX, USA
    • Corresponding Author InformationCorresponding author. P.O. Box 4000, Mail stop J.4404, Princeton, NJ 08543, USA. Tel.: +1 609 252 4575; fax: +1 609 252 6701

Received 9 February 2005; accepted 8 March 2005.

Abstract 

Objective

This study was designed to determine if patients with ketosis-prone diabetes could be distinguished clinically on the basis of features of the metabolic syndrome (MetS).

Methods

Participants with ketosis-prone diabetes admitted to our institution during a 3-year period were studied. One hundred seventy-two patients from four ethnic backgrounds were divided into two groups: with or without MetS, as defined by the World Health Organization. Pearson's chi-square test or one-way ANOVA was used as appropriate to evaluate group differences.

Results

Of the 172 patients, 74 (43%) had at least three characteristics of MetS (+MetS group), while 98 (57%) had less than three characteristics of MetS (−MetS group). The +MetS group had significantly higher β-cell functional reserve as measured by the glucagon stimulation test [area under the curve (AUC) for C-peptide levels 19.50±2.26 compared with 8.66±1.66 ng/ml over 10 min; P=.0001]. A significantly higher proportion of patients in the +MetS group had preserved β-cell functional reserve than in the −MetS group (70% compared with 30%; P<.00001). After 12 months of follow-up, +MetS patients had significantly lower HbA1c levels (8.3±0.4% compared with 9.8±0.4%; P=.01) and higher C-peptide/glucose ratios (2.01±0.28 compared with 1.14±0.21; P=.02) than the −MetS patients did.

Conclusions

Patients with ketosis-prone diabetes with the MetS are more likely to have features associated with Type 2 diabetes, despite having developed diabetic ketoacidosis (DKA), with better β-cell functional reserve and glycemic control after the index DKA episode.

Keywords: Metabolic syndrome, Ketosis-prone diabetes, Ethnicity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1056-8727(05)00026-7

doi:10.1016/j.jdiacomp.2005.03.001

Journal of Diabetes and Its Complications
Volume 19, Issue 6 , Pages 313-318, November 2005